Tolerability and pharmacokinetics of fixed doses of buspirone administered transdermally to healthy subjects.

被引：0
|
作者：
Fulmor, IE
Szylleyko, OJ
Kollia, GD
Ford, NF
Salazar, DE
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
[2] IMTCI, Lenexa, KS USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1999年 / 65卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(99)80201-X
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII83
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics, safety, and tolerability of single and multiple-doses of pinocembrin injection administered intravenously in healthy subjects.
    Cao, Guoying
    PHARMACOTHERAPY, 2014, 34 (10): : E221 - E222
  • [2] SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE AND MULTIPLE DOSES OF ABT-493 IN HEALTHY SUBJECTS.
    Lin, C.
    Dutta, S.
    Clifton, J., II
    Asatryan, A.
    Campbell, A.
    Liu, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S68 - S69
  • [3] EVALUATE THE EFFECT OF ORAL DOSES OF IBREXAFUNGERP ON THE PHARMACOKINETICS OF DABIGATRAN ADMINISTERED ORALLY TO HEALTHY SUBJECTS.
    Azie, N.
    Angulo, D.
    Wabnitz, P.
    Murphy, G.
    Ghahramani, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S12 - S12
  • [4] PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF INHALED REMDESIVIR IN HEALTHY SUBJECTS.
    Humeniuk, R.
    Juneja, K.
    Chen, S.
    Ellis, S.
    Xiao, D.
    Share, A.
    Johnston, M.
    Davies, S.
    Blair, C.
    Osinusi, A.
    Girish, S.
    Palaparthy, R.
    Dresser, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S26 - S26
  • [5] PHARMACOKINETICS, TOLERABILITY AND SAFETY OF ABT-530 FOLLOWING SINGLE AND MULTIPLE DOSES IN HEALTHY SUBJECTS.
    Lin, C.
    Dutta, S.
    Clifton, J., II
    Asatryan, A.
    Campbell, A.
    Liu, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S69 - S69
  • [6] Safety, tolerability, pharmacokinetics and pharmacodynamics of irbesartan after single and multiple doses in healthy male subjects.
    Marino, MR
    Langenbacher, KM
    Ford, NF
    Uderman, HD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PII53 - PII53
  • [7] Entecavir pharmacokinetics after multiple doses in healthy subjects.
    Yan, JH
    Bifano, M
    Nichola, P
    O'Mara, E
    Loizillon, E
    Zhang, DX
    Olsen, S
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1070 - 1070
  • [8] Pharmacokinetics, safety, and tolerability of ascending single intravenous doses of oritavancin administered to healthy human subjects
    Bhavnani, SM
    Owen, JS
    Loutit, JS
    Porter, SB
    Ambrose, PG
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 50 (02) : 95 - 102
  • [9] The effect of dosing regimen on the pharmacokinetics of risedronate administered to healthy subjects.
    Mitchell, DY
    Eusebio, RA
    Heise, MA
    Pallone, KA
    Clay, ME
    Russell, DA
    Melson, CW
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : M661 - M661
  • [10] EFFECT OF MULTIPLE DOSES OF ISAVUCONAZOLE ON THE PHARMACOKINETICS OF METFORMIN IN HEALTHY SUBJECTS.
    Desai, A.
    Yamazaki, T.
    Kowalski, D.
    Lademacher, C.
    Pearlman, H.
    Rammelsberg, D.
    Townsend, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S41 - S41
12345